Table of Contents
- Product Overview & Specifications
- Applications & Detailed Uses
- Usage Guidelines
- Case Studies
- Client Examples
- Contact for Quotation
n-Boc-O-benzyl-D-serine (CAS 47173-80-8): Product Overview & Specifications
Key Specifications
| Parameter | Details |
|---|---|
| CAS Number | 47173-80-8 |
| Molecular Formula | C15H21NO5 |
| Molecular Weight | 295.33 g/mol |
| Appearance | White to off-white crystalline powder |
| Purity (HPLC) | ≥98% |
| Storage Conditions | 2-8°C in airtight container |
Comparative Analysis
| Feature | n-Boc-O-benzyl-D-serine | Standard D-Serine Derivatives |
|---|---|---|
| Protection Groups | Dual (Boc & Benzyl) | Single protection common |
| Solubility | Soluble in DCM, DMF | Limited solvent compatibility |
| Stability | 12-24 months | 6-12 months typical |
Applications & Detailed Uses
Primary Applications
- Peptide synthesis (orthogonal protection strategy)
- Pharmaceutical intermediates for kinase inhibitors
- Glycopeptide antibiotic research
- Chiral building blocks in asymmetric synthesis
Industry-Specific Uses
- Oncology Research: Key intermediate for PARP inhibitors
- Antiviral Drugs: Used in HIV protease inhibitor development
- Neurological Studies: NMDA receptor modulation research
Usage Guidelines
Recommended Protocols
- Deprotection: Use TFA for Boc removal (1-2h at 0°C)
- Coupling: Employ HOBt/DIC in DMF at -20°C
- Storage: Maintain nitrogen atmosphere for long-term storage
Safety Considerations
- Use PPE (gloves, goggles) during handling
- Avoid strong oxidizing agents
- Store separately from bases
Case Studies
Case 1: Peptide Drug Development
Challenge: Low yield (32%) in solid-phase synthesis
Solution: Implemented orthogonal protection strategy using n-Boc-O-benzyl-D-serine
Outcome: Yield improved to 78% with 99% enantiomeric excess
Case 2: Antibiotic Research
Challenge: Glycosylation inefficiency in vancomycin analogs
Solution: Utilized benzyl protection for selective OH group activation
Result: Achieved 92% glycosylation efficiency
Client Examples
Pharmaceutical Company A (Top 10 Global)
- Application: PARP inhibitor intermediate
- Order History: 50kg/year since 2022
- Purity Requirement: ≥99% (custom synthesis)
Research Institute B (EU-based)
- Usage: Neurological disorder studies
- Publication: 3 papers using this compound
- Feedback: Cited 98% batch consistency
Contact for Quotation
Request custom synthesis options or bulk pricing:
Email: info@vivalr.com
Phone: (86) 15866781826
Why Choose Us?
- GMP-certified production facilities
- ISO 9001:2015 quality management
- 24/7 technical support team



评论
目前还没有评论。